معرفی
Mikko Hurme is a researcher at the University of Tampere's School of Medicine, Department of Psychiatry, with a distinguished career spanning nearly three decades (1997-2025). His research primarily focuses on aging mechanisms, particularly through large-scale international studies including MARK-AGE and the Finnish Vitality 90+ Study. He has contributed to 302 research outputs and 2 datasets, with consistent publication activity throughout his career.
His research interests center on DNA methylation, epigenetic biomarkers of aging, and gerontological health assessment. The fingerprint analysis of his work reveals strong expertise in DNA Methylation (100%), Aging (54%), Epigenome-wide Association Studies (51%), and research with Older Adults (42%). His work significantly contributes to UN Sustainable Development Goals related to health and well-being.
Hurme's recent publications (2024-2025) demonstrate continued innovation in identifying biomarkers of aging, with particular focus on epigenetic modifications, cognitive frailty, and metabolic health in elderly populations. His work bridges molecular mechanisms with clinical gerontology.
Hurme has participated in 18 professional activities, primarily conference presentations related to aging research. His most notable contributions include multiple presentations on the Vitality 90+ Study examining socioeconomic status, biomarkers, mobility, and mortality in nonagenarians.
His collaborative network spans multiple European institutions, with significant contributions to major aging studies including MARK-AGE, Report-Age, and the Young Finns Study. He frequently collaborates with researchers across disciplines including genetics, cardiology, and neuroscience.
